Oracle's stock has fallen more than 50% in the past year, hitting a 52-week low despite strong earnings and a $7 billion Pentagon deal. The decline is mainly due to investor concerns over Oracle's costly $300 billion, 5-year partnership with AI firm OpenAI, which may struggle to meet its payment obligations. Oracle has also raised $40 billion through debt and equity to fund this AI project, increasing financial risk. If the AI boom fails, Oracle and founder Larry Ellison's fortunes could be severely impacted.
The global AI in Medical Coding market, valued at $3 billion in 2025, is projected to grow to $10.6 billion by 2035 at a 13.5% CAGR. Growth is fueled by increasing adoption of AI technologies in healthcare for automated coding, fraud detection, and r...
Oracle's stock has fallen about 41% year-to-date, trading at a discount due to heavy AI-related spending, negative free cash flow, and a BBB- credit rating. Despite this, Oracle reported a 21% year-over-year revenue increase in Q4, with cloud infrast...
Oracle Corp's stock has dropped 22% amid concerns over margin and free cash flow pressures due to heavy investments in Oracle Cloud Infrastructure (OCI). Despite this, the company's Cloud segment shows strong revenue growth of 39% year-over-year, wit...
